368 filings
Page 4 of 19
8-K
pl1 iji4egx4
10 Aug 23
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:20pm
8-K
ic6y73 1du6w
21 Jul 23
Other Events
4:37pm
8-K
3pyw 5vd1zgai80
5 Jul 23
Departure of Directors or Certain Officers
4:15pm
4
d0zel338ea10bwvsiixs
5 Jul 23
AVENUE THERAPEUTICS / Faith L. Charles ownership change
4:10pm
4
1izhiqy
5 Jul 23
AVENUE THERAPEUTICS / David Jin ownership change
4:09pm
4
fu2jq3asxeg3g361
5 Jul 23
AVENUE THERAPEUTICS / LINDSAY A MD ROSENWALD ownership change
4:08pm
4
zdou3c2h4g3htqk0d7v
5 Jul 23
AVENUE THERAPEUTICS / JAY D KRANZLER ownership change
4:08pm
4
dgzr 8twwd85s8
5 Jul 23
AVENUE THERAPEUTICS / Curtis Gale Oltmans ownership change
4:07pm
4
xr40w
5 Jul 23
AVENUE THERAPEUTICS / Neil Herskowitz ownership change
4:07pm
4
7nq7 b95sbfaqmr70h
3 Jul 23
AVENUE THERAPEUTICS / Alexandra MacLean ownership change
1:05pm
424B3
exr0cc5v bg8un
28 Jun 23
Prospectus supplement
4:56pm
EFFECT
q5eyo21k6ii8v t2hy
28 Jun 23
Notice of effectiveness
12:15am
8-K
xryq3pmztv7gl3c2hn
26 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
CORRESP
qtvl7d1 b98zt
23 Jun 23
Correspondence with SEC
12:00am
UPLOAD
g2eyqb9 5tf7e3cuhk
22 Jun 23
Letter from SEC
12:00am
8-K
g0297l es
22 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
olvnxycupidn33jw
12 May 23
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:35am
424B3
iypd2z2 czk6
4 May 23
Prospectus supplement
4:30pm